1Supervision and approval of advanced therapy medicinal products in European and its inspirationsCHEN Yun, LI Shan-shan, SHAO Rong, ZHOU Bin1681-16902Research on the interim fund for high-value innovative drugs:based on the empirical study of cancer drugs fund in englandDING Jin-xi, WU Yi-fei, LI Jia-ming, LI Wei1691-16963Analysis of FDA inspection on pharmaceutical manufacturing industry in ChinaYAN Ruo-xi, CAO Yi, DONG Jiang-ping1697-17014Considerations on the necessity of efficacy clinical trials for influenza vaccineLIU Bo, DENG Xia, WANG Yuan-zheng, YIN Xiao, SU Yao, ZHANG Yan, LI Ying-li, GAO Chen-yan, YANG Huan1702-17065Considerations in bioequivalence study for potassium chloride sustained-release tabletsLIU Shu-jie, LI Min, MA Jing-yi, WANG Ke-zhan, YANG Jin-bo1707-17106General considerations on the selection of relevant species for immune-oncology drugsGONG Xin-jiang, SHAO Xue, HUANG Fang-hua, CEN Xiao-bo, HU Xiao-min, WANG Hai-xue, WANG Qing-li1711-17167Specific considerations in the implementation of S9 in ICH guideline in ChinaYE Xuan, ZHANG Min, YAN Li-ping, YU Bing, WANG Hai-xue1717-17228Non-clinical research strategy for the treatment of fundus diseasesWANG Ruo-nan, QIAN Yi-min, SONG Shuo, LI Hua, MA Jing1723-17289Research advances on bioactivity and pharmacological effects of chicoric acidWANG Yu-zhen, GAO Shuang, LI Ling-jun, ZHANG Li, SUN Yue, BO Fu-min1729-173310Considerations on the clinical trials of mesenchymal stem cells for the treatment of novel coronavirus infected pneumonia in patientsGAO Jian-chao, WAN Zhi-hong, HUANG Yun-hong, WANG Hui-cheng, GAO Chen-yan1734-173711Research progress in clinical trials of COVID-19LOU Ning, HAN Xiao-hong1738-174512Dose exploration design of phase Ⅰ clinical trial of new drugs in foreign countries and its enlightenment to ChinaLIU Jin, YANG Jia-ying, ZHU Wen-bo, SHAO Feng, ZHOU Chen, WANG Lu, LI Tian-ping, WANG Xiu-qin, LIANG Ning-xia1746-175113An analysis of job stressors for chinese clinical research coordinatorsZHANG Bang-yu, LI Yu-ping, ZHANG Peng, XU Ying, ZHOU Bin1752-175614Safety of pembrolizumab in the treatment of advanced malignant melanomar: a Meta-analysisYIN Yue, ZHAO Zhi-gang, ZHANG Yan-hua1757-176315Preparation and structure determination of a crystal form of ceftazidimeWANG Yan, ZHANG Dou-sheng, TIAN Ye, MENG Hong-mei, ZHANG Yan-min, LIU Fei, HU Chang-qin, ZOU Wen-bo, XU Ming-zhe1764-176916Determination of residual proteins in the penicillin antibiotics produced by enzymatic process with microfluidic chip-based capillary electrophoresisWANG Yan, YAO Shang-chen, YIN Li-hui, HU Chang-qin, MENG Hong-mei, ZHANG Yan-min, ZOU Wen-bo, XU Ming-zhe1770-177717Rapid assessment on quality of cefuroxime sodium by ATR-FTIR combing with clustering analysisWANG Yan, QI Shu-ye, XUE Jing, YAO Shang-chen, MU Qun-fang, MENG Hong-mei, ZHANG Yan-min, HU Chang-qin, ZOU Wen-bo, XU Ming-zhe1778-178418Determination of 18 amino acids in Rhizoma gastrodiae extract by precolumn derivation HPLCJIANG Qing-wei, WANG Wei, LIU Shu-chang, ZHANG Yin-guang, WANG Mi-juan, ZHANG Meng1785-179019Determination of valsartan and amlodipine in compound tablets using UPLCWANG Wei, DU Xiao-si1791-179420Analysis of tirofiban-induced adverse drug reactions and its preventive measuresYANG Xiao-yu, HU bin, WANG Hui-chuan, CHEN Sheng, XUE Xiao-rong1795-1800 